Jack Saunders
Postdoctoral Researcher
I am a Postdoctoral Researcher in Prof Teresa Lambe’s team within the Oxford Vaccine Group. My current research focuses on characterising clinical and preclinical immune responses to Crimean-Congo haemorrhagic fever (CCHF) and other viral haemorrhagic fevers, with the aim of understanding and improving vaccine-induced immunity.
I recently completed my DPhil in the Oxford Vaccine Group, where I focused on the development and preclinical evaluation of vaccines against CCHF and related nairoviruses. My research explored novel antigen designs across adenoviral-vectored and mRNA vaccine platforms to identify protective candidates and better understand the immune mechanisms underlying protection, alongside supporting the clinical progression of a first-in-human CCHF vaccine.
Prior to my DPhil, I worked as a Research Assistant at the Jenner Institute on CCHF and SARS-CoV-2. I hold a BSc in Biochemistry from the University of Exeter and an MSc in Integrated Immunology from the University of Oxford.
Recent publications
Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean-Congo haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human, non-randomised, phase 1 clinical trial.
Journal article
Pollock KM. et al, (2026), Lancet Infect Dis
Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study.
Journal article
Saunders JE. et al, (2026), EBioMedicine, 133
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
Journal article
Saunders JE. et al, (2023), EBioMedicine, 90
An attenuated herpesvirus vectored vaccine candidate induces T-cell responses against highly conserved porcine reproductive and respiratory syndrome virus M and NSP5 proteins that are unable to control infection.
Journal article
de Brito RCF. et al, (2023), Front Immunol, 14
Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.
Journal article
Belij-Rammerstorfer S. et al, (2022), Front Vet Sci, 9